| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |